prostaglandin E2

Overview

Prostaglandin E2 (PGE2) is a bioactive lipid mediator belonging to the prostaglandin family of eicosanoids, biosynthesized from arachidonic acid through the sequential actions of phospholipase A2 and Prostaglandin-endoperoxide synthase 2 (COX-2). It is one of the most widely studied and pleiotropic of all prostanoid signaling molecules, playing central roles in the regulation of inflammation, pain sensitization, fever, immune modulation, and vascular tone. PGE2 exerts its effects by binding to four G-protein-coupled receptor subtypes (EP1–EP4), enabling context-dependent downstream signaling that can either promote or resolve inflammatory responses depending on tissue and cellular environment. Elevated PGE2 production is a hallmark of acute and chronic inflammatory states, and its measurement in biological fluids and tissues serves as a widely accepted biomarker of inflammatory activity.

Beyond classical inflammation, PGE2 occupies a critical role at the interface of immunity and oncology. Within the tumor microenvironment, PGE2 functions as a potent immunosuppressive mediator, dampening antitumor immune responses alongside factors such as VEGFA and interleukin-6. Its involvement in oxidative stress signaling, including cross-talk with nuclear factor erythroid 2-related factor 2 (NRF2) and nuclear factor kappa B (NF-κB) pathways, further positions it as a convergence point for inflammatory and redox regulation across multiple disease contexts. Therapeutic strategies targeting PGE2 biosynthesis — most prominently through COX-2 inhibition — remain among the most clinically deployed anti-inflammatory interventions in medicine.

Focus of Latest Publications

Recent publications have examined prostaglandin E2 (PGE2) in several distinct biological and clinical contexts, most often as part of inflammatory, neuroimmune, or tissue-injury pathways. In autism spectrum disorder, plasma PGE2 was evaluated alongside glutaminase and 8-isoprostane as a biomarker panel in children with ASD and age-matched controls. PGE2 showed a significant positive correlation with 8-isoprostane, and although PGE2 alone had good diagnostic performance, combining the three markers in a multivariable ROC model substantially increased apparent discrimination. The authors emphasized that this improved performance was observed in a case-control setting and requires further validation in clinically representative cohorts.

Other studies focused on PGE2 as a mechanistic mediator downstream of prostaglandin synthesis. In aged mice, podocyte microsomal prostaglandin E synthase-2 (mPGES-2, encoded by Ptges2) was identified as a driver of renal aging, with podocyte-specific Ptges2 deletion reducing glomerulosclerosis, podocyte injury, and renal senescence. The study linked these effects to a PGE2/EP1 signaling axis and also reported secondary benefits on age-related osteoporosis, renal calcitriol, and α-klotho. Pharmacological inhibition of mPGES-2 with SZ0232 produced similar protective effects, supporting mPGES-2 as a druggable regulator of aging-associated kidney and bone dysfunction.

PGE2 was also implicated in inflammatory and stress-related tissue injury. In UVB-exposed skin models, avenanthramide C from oat sprout extract reduced photoaging-associated inflammation and structural damage, including suppression of PGE2 production in a reconstructed human skin model. In a rat model of paclitaxel-induced peripheral neuropathy, celecoxib attenuated thermal and mechanical hypersensitivity and reduced tissue levels of COX-2, PGE2, and MHC, with effects comparable to COX-2 gene silencing. These findings support a COX-2/PGE2 pathway in chemotherapy-induced neuropathy and suggest that celecoxib may be neuroprotective in this setting.

Additional publications linked PGE2 to cell survival and immune regulation. Cetirizine was investigated in transferosomal formulations for alopecia management, with the rationale that cetirizine may promote hair growth by increasing PGE2 expression. In tobacco heating product–exposed erythrocytes, PGE2-dependent calcium influx contributed to eryptosis, and cyclooxygenase inhibition prevented phosphatidylserine exposure. In bladder cancer, tumor-derived PGE2 suppressed differentiation of CCR6hiCD4+ T cells into immunostimulatory CCL5hiCD4+ T cells, thereby impairing macrophage polarization and promoting resistance to checkpoint inhibitor therapy. Together, these studies portray PGE2 as a recurring mediator of inflammation, tissue remodeling, cell death, and immune suppression across diverse disease models.

Key Publications

NEWJun Using combined ROC curves to improve the diagnostic usefulness of glutaminase, prostaglandins, and 8-isoprostane as biomarkers of autism spectrum disorders;Role in the Glu-GABA-Gln cycle. (BMC neuroscience, 2026, PMID 42343199): "Plasma levels of glutaminase, 8-isoprostane, and prostaglandin E2 (PGE2) obtained from 44 children with ASD and 40 age-matched controls were evaluated using receiver operating characteristic (ROC) analysis, both individually and in combined ROC models."
NEWJul Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis. (Aging cell, 2026, PMID 42347750): "Mechanistically, mPGES-2 promoted podocyte senescence through a PGE2/EP1 signaling axis."
Jun Protection of skin from UVB-induced photoaging: Antioxidant and anti-inflammatory effects of avenanthramide C from oat sprout extract via suppression of MAPK pathways. (Journal of photochemistry and photobiology. B, Biology, 2026, PMID 42102478): "AVN C protected against UVB-induced structural damage and inflammation by suppressing prostaglandin E2 production."
May Celecoxib Mitigates Paclitaxel-Induced Peripheral Neuropathy Through Modulation of the COX-2/PGE2 Pathway in Rats. (FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026, PMID 42048120): "Celecoxib also downregulated paclitaxel-induced upregulation of COX-2, PGE2, and MHC in these tissues."
Apr Targeted transferosomal delivery of cetirizine: A new approach to alopecia management. (PloS one, 2026, PMID 42030261): "Cetirizine (CET), an antihistamine, may induce hair growth by increasing prostaglandin E2 expression."
May Tobacco heating product aerosol triggers PKC-dependent eryptosis: biochemical insights. (Chemico-biological interactions, 2026, PMID 41796629): "HTPE exposure caused a strong, PGE2-dependent calcium influx essential for eryptosis, as both calcium chelation and cyclooxygenase inhibition prevented phosphatidylserine exposure."
May CCL5 hiCD4+ T Cells Regulate Macrophage Polarization and Promote Immunotherapy Response in Bladder Cancer. (Cancer research, 2026, PMID 41706539): "Importantly, tumor-derived prostaglandin E2 (PGE2) acted as a critical microenvironmental factor that suppressed the differentiation of CCR6hiCD4+ T cells into immunostimulatory CCL5hiCD4+ T cells, thereby driving resistance to ICI therapy."